Prolonging the Overall Survival by Vaccination of autologous tumor lysate-loaded dendritic Cells (DCVax-L) in Patients with newly diagnosed and recurrent Glioblastoma

被引：0
|
作者：
Deng, Maximilian Y. [1 ,2 ,3 ]
Debus, Juergen [1 ,2 ,3 ,4 ]
Koenig, Laila [1 ,2 ,3 ]
机构：
[1] Univ Klinikum Heidelberg, Klin Radioonkol & Strahlentherapie, Neuenheimer Feld 400, D-691201 Heidelberg, Germany
[2] Heidelberger Ionenstrahl Therapiezentrum HIT, Neuenheimer Feld 450, D-69120 Heidelberg, Germany
[3] Natl Ctr Tumorerkrankungen NCT Heidelberg, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[4] Deutsch Krebsforschungszentrum DKFZ, Klin Kooperationseinheit Strahlentherapie, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷 / 03期
关键词：
RESPONSE ASSESSMENT; CRITERIA;
D O I：
10.1007/s00066-023-02049-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
  • [11] A phase I clinical trial in patients with newly diagnosed glioblastoma vaccinated with autologous dendritic cells pulsed with autologous tumor lysate.
    Boynton, A. L.
    Prins, R.
    Bosch, M.
    Yang, M.
    Odesa, S. K.
    Khan-Farooqi, H.
    Cloughesy, T.
    Liau, L.
    CYTOTHERAPY, 2006, 8
  • [12] The clinical utility of autologous tumor lysate-loaded dendritic cell vaccination for patients with glioma: A systematic review and meta-analysis
    Habibi, Mohammad Amin
    Mirjani, Mohammad Sina
    Ahmadvand, Muhammad Hussain
    Delbari, Pouria
    Arab, Shayan
    Minaee, Poriya
    Eazi, Seyedmohammad
    Ahmadpour, Sajjad
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 671 - 680
  • [13] VACCINATION OF DENDRITIC CELLS LOADED BY ELECTROPORATION WITH AUTOLOGOUS TUMOR LYSATE FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: EVALUATION OF SAFETY AND IMMUNE RESPONSE
    Kanemura, Yonehiro
    Sumida, Miho
    Yoshioka, Ema
    Yamamoto, Atsuyo
    Kanematsu, Daisuke
    Takada, Ai
    Nonaka, Masahiro
    Nakajima, Shin
    Goto, Shigenori
    Kamigaki, Takashi
    Takahara, Masashi
    Maekawa, Ryuji
    Shofuda, Tomoko
    Moriuchi, Shusuke
    Yamasaki, Mami
    NEURO-ONCOLOGY, 2013, 15 : 70 - 70
  • [14] COMPARISON OF GLIOMA-ASSOCIATED ANTIGEN PEPTIDE-LOADED VERSUS AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IN MALIGNANT GLIOMA PATIENTS
    Prins, Robert M.
    Everson, Richard
    Soto, Horacio
    Lisiero, Dominique N.
    Young, Emma
    Liau, Linda M.
    NEURO-ONCOLOGY, 2012, 14 : 48 - 49
  • [15] A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
    Matsushita, Hirokazu
    Enomoto, Yutaka
    Kume, Haruki
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Homma, Yukio
    Kakimi, Kazuhiro
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
  • [16] Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients
    Prins, Robert M.
    Wang, Xiaoyan
    Soto, Horacio
    Young, Emma
    Lisiero, Dominique N.
    Fong, Brendan
    Everson, Richard
    Yong, William H.
    Lai, Albert
    Li, Gang
    Cloughesy, Timothy F.
    Liau, Linda M.
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (02) : 152 - 157
  • [17] Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
    Fadul, Camilo E.
    Fisher, Jan L.
    Hampton, Thomas H.
    Lallana, Enrico C.
    Li, Zhongze
    Gui, Jiang
    Szczepiorkowski, Zbigniew M.
    Tosteson, Tor D.
    Rhodes, C. Harker
    Wishart, Heather A.
    Lewis, Lionel D.
    Ernstoff, Marc S.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (04) : 382 - 389
  • [18] A phase II clinical trial to test the efficacy of DCVax-brain, autologous dendritic cells pulsed with autologous tumor lysate, for the treatment of patients with glioblastoma multiforme
    Bosch, Marnix
    Boynton, Alton
    Prins, Robert
    Liau, Linda
    NEURO-ONCOLOGY, 2007, 9 (04) : 509 - 509
  • [19] A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial
    Rapp, Marion
    Grauer, Oliver M.
    Kamp, Marcel
    Sevens, Natalie
    Zotz, Nikola
    Sabel, Michael
    Sorg, Ruediger V.
    TRIALS, 2018, 19
  • [20] A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial
    Marion Rapp
    Oliver M. Grauer
    Marcel Kamp
    Natalie Sevens
    Nikola Zotz
    Michael Sabel
    Rüdiger V. Sorg
    Trials, 19
12345